|
Fri, 05/03/2019 - 14:28 |
FDA Approves Genentech's Kadcyla for Adjuvant Treatment of People With HER2-Positive Early Breast Cancer With Residual Invasive Disease After Neoadjuvant Treatment |
Genentech |
|
Thu, 12/06/2018 - 10:18 |
Shellfish biotoxin alert for the Bay of Islands in Northland |
MPI NZ |
|
Wed, 12/05/2018 - 21:55 |
FDA Approves Genentechs Tecentriq in Combination With Avastin and Chemotherapy for the Initial Treatment of People With a Specific Type of Metastatic Lung Cancer |
Genentech |
|
Tue, 12/04/2018 - 23:19 |
Genentechs Kadcyla Cut the Risk of Disease Recurring by Half Compared to Herceptin in People With HER2-Positive Early Breast Cancer With Residual Disease After Neoadjuvant Treatment |
Genentech |
|
Mon, 12/03/2018 - 20:55 |
FDA Grants Priority Review to Genentechs Tecentriq in Combination With Chemotherapy for the Initial Treatment of Extensive-Stage Small Cell Lung Cancer |
Genentech |
|
Fri, 11/16/2018 - 16:43 |
Simian Herpes Is Nothing To Monkey Around With |
American Counci... |
|
Mon, 11/12/2018 - 10:37 |
FDA Grants Priority Review to Genentechs Tecentriq in Combination With Abraxane for the Initial Treatment of People With PD-L1-Positive, Metastatic Triple-Negative Breast Cancer |
Genentech |
|
Tue, 11/06/2018 - 11:32 |
FDA grants priority review for Dupixent (dupilumab) as potential treatment for adolescents with uncontrolled moderate-to-severe atopic dermatitis |
Genzyme |
|
Mon, 10/22/2018 - 09:34 |
Genentechs Tecentriq Plus Chemotherapy (Carboplatin and Abraxane) as an Initial Treatment Helped People With Advanced Non-Squamous Non-Small Cell Lung Cancer Live Significantly Longer Compared to Chemotherapy Alone |
Genentech |
|
Sun, 10/21/2018 - 21:57 |
State REMOVES Cyanobacteria Lake Warning for Arlington Mill Pond in Salem, New Hampshire |
DES New Hampshire |
|
Fri, 10/19/2018 - 21:22 |
Genentechs Tecentriq in Combination With Abraxane Improves Outcomes as an Initial Treatment for People With PD-L1-Positive Metastatic Triple-Negative Breast Cancer |
Genentech |
|
Thu, 10/18/2018 - 22:57 |
FDA approves asthma indication for Dupixent (dupilumab) |
Genzyme |
|
Sun, 10/14/2018 - 17:56 |
Genentechs Kadcyla Reduced the Risk of Disease Recurring in People With HER2-Positive Early Breast Cancer With Residual Disease After Neoadjuvant Treatment |
Genentech |
|
Wed, 10/10/2018 - 17:57 |
Sanofi presents new data on Aubagio (teriflunomide) |
Genzyme |
|
Mon, 10/08/2018 - 19:48 |
Reversing Paralysis: Stem cell therapy aims to repair spinal cords afflicted by rare disorder |
UTSouthwestern |
|
Sun, 10/07/2018 - 21:17 |
More Than 30 Data Presentations from Sanofi Genzymes Multiple Sclerosis Franchise to Be Featured at the 34th ECTRIMS Congress |
Genzyme |
|
Mon, 10/01/2018 - 20:09 |
Integrative Cancer Care: NDs Work With MDs to Create Better Outcomes |
AANMC |
|
Fri, 09/28/2018 - 04:57 |
FDA Approves Genentech's Xolair (Omalizumab) Prefilled Syringe Formulation |
Genentech |
|
Tue, 09/25/2018 - 03:43 |
Genentechs TECENTRIQ in Combination With Chemotherapy Helped People Live Significantly Longer as an Initial Treatment for People With Extensive-Stage Small Cell Lung Cancer |
Genentech |
|
Mon, 09/24/2018 - 03:10 |
Genentechs TECENTRIQ in Combination With Pemetrexed and Platinum-Based Chemotherapy Reduced the Risk of Disease Worsening or Death in a Type of Previously Untreated Advanced Lung Cancer |
Genentech |
|
Thu, 09/13/2018 - 00:15 |
Symptom Science Study Seeks to Develop Deeper Understanding of HIV-Related Neuropathic Pain |
NewYorkUniversity |
|
Fri, 09/07/2018 - 15:40 |
State REMOVES Cyanobacteria Lake Warning for Hunkins Pond in Sanbornton, New Hampshire |
DES New Hampshire |
|
Fri, 09/07/2018 - 09:26 |
FDA approves new dosage strength of buprenorphine and naloxone sublingual film as maintenance treatment for opioid dependence |
FDA |
|
Tue, 09/04/2018 - 23:58 |
Genentech to Present New Data from Its Extensive Lung Cancer Program at the 2018 World Conference on Lung Cancer (WCLC) |
Genentech |
|
Wed, 08/29/2018 - 12:47 |
State REMOVES Cyanobacteria Lake Warning for Lake Winona in New Hampton and Center Harbor, New Hampshire |
DES New Hampshire |
